What Is Percutaneous Coronary Intervention?
If you or someone you love has been told they have blocked coronary arteries, there is a good chance the term percutaneous coronary intervention — or PCI — has come up in conversation. You may have also heard it called angioplasty, stenting, or simply "having a stent put in." These terms all describe variations of the same core procedure, and understanding exactly what PCI involves is the first step toward making a clear-headed decision about your care.
As a fellowship-trained structural and interventional cardiologist, I perform these procedures regularly. PCI is a catheter-based technique used to open narrowed or blocked coronary arteries — the blood vessels that supply oxygen to your heart muscle. During the procedure, a thin, flexible catheter is guided through an artery in your wrist or groin, threaded up to the heart, and positioned at the site of the blockage. A tiny balloon at the tip of the catheter is inflated to compress the plaque against the artery wall, and in most cases, a small mesh tube called a coronary stent is placed to hold the artery open.
The entire procedure is typically performed under conscious sedation — not general anesthesia. Most patients are awake. Most go home the same day or the following morning. There is no sternotomy, no heart-lung machine, and no weeks-long recovery in the traditional surgical sense. That is why PCI is sometimes described as "minimally invasive," though I prefer to be more specific: it is a percutaneous procedure, meaning it is done through the skin via a small puncture, not through an open incision.
How Coronary Stents Work — and Why the Type Matters
A coronary stent is a small, expandable metallic scaffold that props open a diseased artery after balloon angioplasty. Without a stent, the artery has a high rate of re-narrowing — a process called restenosis. Early bare-metal stents reduced that risk significantly, but the real game-changer came with the development of drug-eluting stents (DES), which are coated with medication that inhibits the overgrowth of tissue inside the stent.
Modern drug-eluting stents have dramatically reduced restenosis rates to roughly 5-10%, compared to 20-30% with bare-metal stents. According to ACC/AHA guidelines, drug-eluting stents are now the standard of care for the vast majority of PCI procedures. If your cardiologist recommends a bare-metal stent instead, it is worth asking why — there are specific clinical scenarios where that choice makes sense (for example, if you need non-cardiac surgery very soon and cannot stay on dual antiplatelet therapy), but those situations are relatively uncommon.
After a coronary stent is placed, you will be prescribed blood-thinning medications — typically aspirin plus a second antiplatelet drug such as clopidogrel (Plavix), prasugrel (Effient), or ticagrelor (Brilinta). This dual antiplatelet therapy (DAPT) is critical. It prevents blood clots from forming inside the stent during the period when the artery lining is healing around the metal. Stopping these medications prematurely is one of the most dangerous things a patient can do after stenting. If anyone — a dentist, an orthopedic surgeon, anyone — tells you to stop your blood thinners without consulting your cardiologist first, pick up the phone and call your cardiologist immediately.
When PCI Is the Right Choice — and When It May Not Be
This is where the conversation gets more nuanced, and where I spend a significant amount of time with my patients. PCI is an excellent tool, but it is not the right tool for every patient with coronary artery disease. Knowing the difference is essential.
PCI is generally well-suited for:
- Acute heart attacks (ST-elevation myocardial infarction, or STEMI): In this setting, emergent PCI — called primary PCI — is the gold standard. Opening the culprit artery as quickly as possible saves heart muscle and saves lives. The data here are unequivocal.
- Acute coronary syndromes (unstable angina or non-ST-elevation MI): An early invasive strategy with PCI often reduces the risk of recurrent events, particularly in higher-risk patients.
- Single-vessel or focal two-vessel coronary artery disease with preserved heart function: When there is one or two discrete blockages in favorable anatomy, PCI with drug-eluting stents delivers excellent results with a rapid recovery.
- Patients with significant surgical risk: Older patients, those with severe lung disease, prior chest surgery, or other comorbidities that make open-heart surgery high risk may be better served by a catheter-based approach.
PCI may not be the best option for:
- Complex multi-vessel coronary artery disease, particularly involving the left main coronary artery or proximal left anterior descending artery in patients with diabetes
- Diffusely diseased arteries that are not amenable to focal stenting
- Patients with reduced heart function (low ejection fraction) and extensive disease, where complete revascularization with bypass surgery has been shown to improve survival
- Chronic total occlusions in certain anatomic patterns where surgical bypass may offer a more durable result
These are not abstract distinctions. They have real consequences. The landmark SYNTAX trial and its 10-year follow-up data demonstrated that for patients with complex three-vessel or left main coronary disease, coronary artery bypass grafting (CABG) was associated with lower rates of death, heart attack, and repeat revascularization compared with PCI. The FREEDOM trial showed a clear survival advantage for CABG over PCI in diabetic patients with multi-vessel disease. These studies form the backbone of current guidelines and should inform every treatment recommendation.
If you have been told you need a stent and you are not sure whether surgery was adequately considered — or vice versa — that uncertainty alone is reason enough to seek a second opinion from an independent specialist.
PCI vs CABG: How to Think About the Decision
The PCI vs CABG question is one of the most consequential decisions in cardiac care, and it deserves a thoughtful, individualized answer — not a reflexive one. I say this as someone who performs PCI for a living: the best procedure is the one that gives you the best long-term outcome, even if that means referring you to a surgeon.
Here is a framework I use when discussing this with patients:
1. What does the anatomy look like? The number of vessels involved, the location of the blockages, and the complexity of the disease matter enormously. A tool called the SYNTAX score — derived from the angiogram — helps quantify anatomic complexity. A low SYNTAX score (under 22) suggests PCI and CABG are likely equivalent. A high SYNTAX score (over 32) generally favors surgery. Scores in between require careful clinical judgment.
2. Do you have diabetes? Diabetes significantly influences the PCI vs CABG discussion. Multiple randomized trials have shown that diabetic patients with multi-vessel disease do better with bypass surgery. This is partly because diabetic patients tend to develop more diffuse plaque and are at higher risk for in-stent restenosis and disease progression in untreated segments.
3. What is your heart function? If your ejection fraction is reduced — meaning your heart is pumping less effectively — complete revascularization with CABG may offer a survival benefit that PCI does not match, particularly when the disease is extensive.
4. What are your surgical risks? Age, frailty, prior surgery, lung function, kidney function, and other medical conditions all factor in. You can get a preliminary estimate using a free cardiac surgery risk calculator, but the final assessment should always come from an experienced team.
5. What matters most to you? PCI offers a quicker recovery and avoids a major operation. CABG typically offers more durable revascularization and a lower need for repeat procedures over 10 or more years. Understanding this tradeoff — shorter recovery versus longer-lasting results — is essential, and it is deeply personal.
One thing I want to be direct about: in some healthcare systems, there are structural incentives that can bias recommendations in one direction or another. A catheterization lab generates revenue when stents are placed. A surgical program generates revenue when bypasses are performed. This is not a commentary on any individual physician's integrity — the vast majority of cardiologists and surgeons I work with are deeply ethical. But it is a reason why an independent review of your case by a physician with no financial stake in the outcome can be profoundly valuable.
What to Ask Your Cardiologist Before Agreeing to PCI
If percutaneous coronary intervention has been recommended for you, here are specific questions worth asking:
- How many vessels are significantly blocked, and where are the blockages?
- What is my SYNTAX score, and was a Heart Team discussion held to review my options?
- Is there a survival benefit to stenting in my case, or is this primarily for symptom relief?
- Would CABG be expected to offer better long-term outcomes for my specific anatomy?
- How long will I need to be on dual antiplatelet therapy, and are there any upcoming procedures or conditions that could complicate that?
- What is the risk of needing another procedure in the next five to ten years?
These are not confrontational questions. They are the questions that a well-informed patient asks, and any experienced cardiologist will welcome them. If the answers you receive feel rushed, vague, or dismissive, that is a signal — not necessarily that the recommendation is wrong, but that you deserve a more thorough conversation.
For patients navigating complex decisions about coronary artery disease, I also recommend reviewing the WhiteGloveMD learning center, which covers related topics including bypass surgery recovery and how to compare treatment options.
The Role of a Second Opinion in PCI and Stenting Decisions
I want to close with something I feel strongly about. In my years of practice, I have seen patients who were stented when they should have had surgery, and I have seen patients sent to the operating room when a well-placed stent would have been sufficient. Neither error is harmless. The first can lead to incomplete revascularization, repeat procedures, and worse long-term survival. The second exposes a patient to the risks and recovery of a major operation they may not have needed.
A second opinion does not mean your first doctor was wrong. It means your decision was important enough to verify. In structural and interventional cardiology, we see the full spectrum — straightforward cases and profoundly complex ones. Sometimes the right answer is obvious. Often, it is not. And in those gray-zone cases, having an independent, fellowship-trained specialist review your catheterization films, imaging, and medical history can change the trajectory of your care.
If you are facing a decision about percutaneous coronary intervention, coronary stenting, or whether PCI or CABG is the better path for your specific situation, a WhiteGloveMD second opinion can help. Our team — including cardiovascular surgeons and interventional cardiologists — will review your complete case and provide a clear, unbiased recommendation so you can move forward with confidence.